Jubilant Life Sciences is currently trading at Rs. 650.70, up by 18.75 points or 2.97% from its previous closing of Rs. 631.95 on the BSE.
The scrip opened at Rs. 649.00 and has touched a high and low of Rs. 661.65 and Rs. 648.50 respectively. So far 27644 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 705.05 on 01-Nov-2016 and a 52 week low of Rs. 272.50 on 20-Jan-2016.
Last one week high and low of the scrip stood at Rs. 686.50 and Rs. 515.00 respectively. The current market cap of the company is Rs. 10416.19 crore.
The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 26.26% and 19.72% respectively.
Jubilant Life Sciences has issued Commercial Papers of Rs 50 crore on November 09, 2016, having maturity date of December 29, 2016, which have been rated IND A1 + by India Ratings & Research. The aggregate amount of Commercial Papers outstanding as on date is Rs 100 crore.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
